Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-986179 alone or with nivolumab in advanced solid tumors
NCT02754141Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jun 2016
- Primary completion
- Oct 2021
- Countries
- 7
01
Overview
A Phase 2 trial of BMS-986179 in malignant solid tumor, sponsored by Bristol Myers Squibb. Started Jun 2016; status: completed.
02
Drugs
BMS-986179
03
Conditions
malignant solid tumor
Beyond the preview
Go deeper on NCT02754141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02754141.